EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 147 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,306,771 | -17.8% | 273,099 | +1.4% | 0.54% | -15.6% |
Q2 2023 | $5,238,127 | -22.1% | 269,451 | +13.7% | 0.63% | -22.4% |
Q1 2023 | $6,720,371 | -0.6% | 236,883 | +2.4% | 0.82% | -1.2% |
Q4 2022 | $6,758,619 | +10.3% | 231,222 | -0.3% | 0.83% | +1.5% |
Q3 2022 | $6,130,000 | -40.6% | 232,021 | -0.1% | 0.82% | -36.1% |
Q2 2022 | $10,323,000 | -11.1% | 232,343 | -1.0% | 1.28% | +5.6% |
Q1 2022 | $11,616,000 | -3.4% | 234,720 | -0.6% | 1.21% | +0.9% |
Q4 2021 | $12,030,000 | -15.6% | 236,251 | -7.5% | 1.20% | -16.5% |
Q3 2021 | $14,254,000 | +20.0% | 255,532 | -7.9% | 1.43% | +36.4% |
Q2 2021 | $11,880,000 | -9.0% | 277,572 | -11.2% | 1.05% | -0.8% |
Q1 2021 | $13,053,000 | +52.0% | 312,717 | +69.6% | 1.06% | +34.1% |
Q4 2020 | $8,589,000 | +7.7% | 184,424 | -1.8% | 0.79% | -13.1% |
Q3 2020 | $7,978,000 | +4.8% | 187,798 | +18.4% | 0.91% | -1.5% |
Q2 2020 | $7,613,000 | +9.6% | 158,671 | +5.1% | 0.92% | -14.8% |
Q1 2020 | $6,948,000 | -17.4% | 151,043 | +7.9% | 1.08% | +32.1% |
Q4 2019 | $8,412,000 | -3.9% | 140,014 | -9.5% | 0.82% | -11.8% |
Q3 2019 | $8,749,000 | +2.2% | 154,654 | +0.6% | 0.93% | +0.9% |
Q2 2019 | $8,557,000 | +90.9% | 153,674 | +73.1% | 0.92% | +87.4% |
Q1 2019 | $4,483,000 | – | 88,784 | – | 0.49% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |